Author: AMP GCG

Home / Articles posted by AMP GCG
Posted on October 22, 2020
Press Release

ERFURT / BERLIN, Germany, and Perth, Western Australia - October 22nd, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028), providing German patients with a wide range of pharmaceutical grade medical cannabis products, is pleased to announce it will be adding Little Green Pharma Ltd. (ASX: LGP) cannabis oil medicines to its catalogue for sale in Germany beginning in November 2020 subject to obtaining a BtM-registration (narcotic drug licence) of these products on behalf of...

by
0
Posted on October 19, 2020
Press Release

ERFURT and BERLIN, Germany, October 19th, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX), (FSE: C4T, ISIN: CA00176G1028), providing German patients with a wide range of pharmaceutical grade medical cannabis products, announces that it has granted incentive stock options to purchase 590,000 common shares of the Company to an officer and employees in accordance with its stock option plan. Each option vests immediately, has an exercise price of C$0.35 per share and expires on September 8,...

by
0
Posted on October 9, 2020
Press Release

ERFURT and BERLIN, Germany, October 9th, 2020, AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, announces that its previously announced non-brokered private placement financing has been increased due to strong investor demand. The private placement was originally announced on September 8, 2020, with the anticipation of raising gross proceeds of $500,000 at a price of $0.35 per share. The private placement was oversubscribed, and a total of approximately $771,956...

by
0
Posted on September 18, 2020
Press Release

ERFURT and BERLIN, Germany - September 18, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028), announces it has closed the first tranche of its non-brokered private placement announced on September 9th, 2020. Under the first tranche, AMP raised gross proceeds of $390,525 through the issuance of 1,115,785 common shares at a subscription price of $0.35 per share and are subject to a four month hold period.  AMP paid a finders’ fee of $1,715 and...

by
0
Posted on September 15, 2020
Press Release

ERFURT and BERLIN, Germany - September 15th, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, is pleased to announce the appointment of Mr. Marc Wälken as Sales Director, effective immediately. Mr. Wälken joins AMP from Spectrum Therapeutics, a brand of Canopy Growth Germany GmbH, a wholly-owned subsidiary of Canopy Growth Corporation (TSX: WEED), one of the largest importers of medical cannabis into Germany, where he was Areas...

by
0
Posted on September 10, 2020
Press Release

ERFURT and BERLIN, Germany, September 10th, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, provides a strategy update on how it plans to supply Germany with EU-GMP medical cannabis products continuously. AMP purchases EU-GMP medical cannabis and imports it through its supply chain management system to Germany and sells directly to pharmacists, the only point of sale to German patients with a physician’s prescription...

by
0
Posted on September 9, 2020
Press Release

ERFURT and BERLIN, Germany, September 8th, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX), (FSE: C4T, ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, announces a non-brokered private placement financing and granting of stock options both priced at C$0.35 per share. AMP intends to raise up to C$500,000 in a non-brokered private placement at an issuance price of C$0.35 per share.  In connection with the offering, the Company may pay a finder’s fee and...

by
0
Posted on August 4, 2020
Press Release

ERFURT and BERLIN, Germany, August 4th, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) proudly presents its first video in a series of in-depth roundtable discussions that will explore and discuss new developments regarding medical cannabis in Germany. The Roundtable Series online videos are in German with English subtitles. AMP Roundtable Series Website: amp-eu.de/roundtable AMP Roundtable Series:  Episode #1, “Medical Cannabis in Germany.” The first episode in the Roundtable Series, “Medical Cannabis in Germany”,...

by
0
Posted on July 21, 2020
Press Release

ERFURT / BERLIN, Germany, July 21st, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (FSE: C4T, ISIN: CA00176G1028) (CSE: XCX) announces it has placed two orders for bulk and finished EU-GMP medical cannabis flower from a Canadian Licensed Producer (“Canadian LP”) of medical cannabis. AMP will be purchasing and importing to Germany, 50 kilograms of EU-GMP medical cannabis in September 2020 and a further 100 kilograms during January/February 2021. AMP and the Canadian LP plan to expand the...

by
2
Posted on July 6, 2020
Press Release

ERFURT and BERLIN, Germany, July 6th, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces further to its June 5, 2020 news release The Office of Medical Cannabis (“OMC”), the government organization of the Netherlands for distribution of medical cannabis products, has notified AMP that it will resume exports of EU-GMP medical cannabis to Germany. The OMC will deliver 3,000 grams per month to each German importer due to the high demand...

by
0